Smoking cessation for psychotic patients facing compulsory treatment in a French inpatient psychiatric unit

Viala, Annie; Benathzmane, Nadia; Cornic, Françoise
January 2007
BMC Psychiatry;2007 Supplement 1, Vol. 7, Special section p1
Academic Journal
Background Patients with a psychotic disorder have consistently been shown to have very high rates of smoking and they have between 2 and 4 times the rates of cardiovascular and respiratory diseases of the general population. The French law of November 2006, decret nø2006-1386, bans smoking in public places and therefore in public hospitals. Methods The study takes place in an inpatient psychiatric unit where free, voluntary and compulsory patients mostly with DSM IVR schizophrenia and mood disorders are hospitalized. Patients facing compulsory treatment arrive in acute or very acute state, often by force, and they need a tailored smoking cessation program, combining nicotine transdermal patches, gums, but also motivational intervention, psychoeducation, diet counselling and physical exercises. Results Nicotine replacement therapy plus motivational intervention and multidisciplinary care are necessary to reduce anxiety, depression and food craving, and they have to go on for months. Antipsychotic medications in combination with transdermal patches may be useful. Alcohol or cannabis addictive disorders worsen the prognosis. Smoking cessation is more difficult for anxious and depressed patients. Young patients are less sensible to health complications than to recovered personal freedom. There is a need to reduce psychotropic medications while carrying out the smoking cessation program. Conclusion Patients with psychotic or mood disorders have a high rate of cigarette smoking. Patients facing compulsory hospitalization must stop in acute state and they need targeted smoking cessation policies in order first to convince, rather than to constrain them: that's a new challenge for them, but for caregivers too.


Related Articles

  • Nicotine replacement is safe in stable CAD.  // Patient Care;6/15/1994, Vol. 28 Issue 11, p162 

    Highlights the results of the study `Working Group for the Study of Transdermal Nicotine in Patients with Coronary Artery Disease: Nicotine replacement therapy for patients with coronary artery disease,' from the journal `Archives of Internal Medicine.' Efficacy of transdermal nicotine patches...

  • Quitters or not, patients still like nicotine patches. Starr, Cynthia // Drug Topics;11/22/93, Vol. 137 Issue 22, p24 

    Presents a study of what patients think of nicotine patches, the process they go through to procure these and what they learned from health professionals involved in their care. Users who are satisfied and who would use the product again if additional treatment were needed; Support from...

  • Transdermal Nicotine Facilitates Smoking Cessation. Rose, Jed E. // JAMA: Journal of the American Medical Association;10/10/90, Vol. 264 Issue 14, p1866 

    Presents an abstract of the study titled 'Transdermal Nicotine Facilitates Smoking Cessation.'

  • Compulsory treatment of the mentally ill.  // British Medical Journal (Clinical Research Edition);3/29/1986, Vol. 292 Issue 6524, p888 

    Focuses on the compulsory treatment of patients who are not detained in hospital as inpatients. Role of medical workers in the intervention of psychiatric cases; Implications of the attitude on the serious deprivation of liberty; Effect of compulsory treatment in temporary detention.

  • From Rogers to Rivers: The Rights of the Mentally Ill to Refuse Medication. Clayton, Ellen Wright // American Journal of Law & Medicine;1987, Vol. 13 Issue 1, p7 

    Many individuals with mental illness wish to avoid psychotropic drugs, a type of treatment that may relieve their symptoms only at the risk of unpleasant, even permanent, side effects. In marked contrast to the widely-held view that most patients may refuse any treatment and that even patients...

  • Nicotine Patches Help Kick the Habit.  // USA Today Magazine;Dec91, Vol. 120 Issue 2559, p13 

    Reports on the benefit of transdermal nicotine patches for people who want to quit smoking. Behavior modification technique; Advantages of patches over nicotine gum; Reduction in withdrawal symptoms; Increase in the likelihood of quitting success.

  • Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment. Rose, Jed E.; Herskovic, Joseph E.; Behm, Frederique M.; Westman, Eric C. // Nicotine & Tobacco Research;Sep2009, Vol. 11 Issue 9, p1067 

    Introduction: Previous studies have reported that smoking abstinence rates are increased when nicotine skin patch treatment is initiated prior to the target quit smoking date, as compared with conventional treatment beginning on the quit date. We hypothesized that smoking in the presence of...

  • NICOTINE PATCH HELPS SMOKERS STAY STOPPED. Begany, Timothy // RN;Nov94, Vol. 57 Issue 11, p19 

    Reports on the benefits of the transdermal nicotine patches for people trying to quit smoking.

  • Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial. Aubin, H-J.; Bobak, A.; Button, J. R.; Oncken, C.; Billing Jr, C. B.; Gong, J.; Williams, K. E.; Reeves, K. R.; Britton, J R; Billing, C B Jr // Thorax;Aug2008, Vol. 63 Issue 8, p717 

    Background: Varenicline, a new treatment for smoking cessation, has demonstrated significantly greater efficacy over placebo and sustained release bupropion (bupropion SR). A study was undertaken to compare a 12-week standard regimen of varenicline with a 10-week standard regimen of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics